Archive · 27 Nov 2025
Glenmark Pharma's Monroe facility resumes production after USFDA clearance
Glenmark Pharma is a company that makes medicines.
They had a factory in Monroe that was not allowed to make products for a while because the USFDA, which checks if medicines are safe, had some concerns.
After two years, the USFDA said the factory can start making medicines again because they fixed the problems.
This is good news for Glenmark Pharma because they can now sell their medicines from this factory again.
Glenmark Pharma's Monroe facility has received USFDA clearance to resume commercial production.
The facility was under regulatory scrutiny for two years.
The USFDA issued an EIR with VAI status, indicating voluntary action is sufficient.
This clearance marks a significant turnaround for the company.
Glenmark Pharma is working to resolve compliance issues across multiple sites.
- Who
- Glenmark Pharma
- What
- Resumption of commercial production at Monroe facility
- When
- After two years of regulatory scrutiny
- Where
- Monroe facility
- Why
- USFDA issued EIR with voluntary action indicated status
- Company
- Glenmark Pharma
- Facility
- Monroe
- Regulatory Body
- USFDA
- Status
- EIR with VAI
- Duration of Scrutiny
- 2 years